A Safety, Tolerability, Pharmacokinetics (PK), and Pharmacodynamics Study

Conditions:   Solid Neoplasms;   Carcinoma, Non-Small-Cell Lung;   Prostatic Neoplasms Intervention:   Drug: TAK-573 Sponsor:   Millennium Pharmaceuticals, Inc. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials